CTVA vs MRVI · P/E 42, rev $16.91B vs rev $117.3M
Corteva Inc (CTVA) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. MRVI currently screens at market cap $1.93B.
Not investment advice. Open the CTVA and MRVI stock pages for the full models.
Not investment advice.